No profile data available.
Collegium Pharmaceutical, Inc. (COLL) is a healthcare company in the opioid pain relief pharmaceuticals industry, based in Stoughton, United States, with about 423 full-time employees.
It reported revenue of $780.57 million for fiscal year 2025, up 23.6% from fiscal year 2024, and net income of $62.87 million. Its market capitalization was $719.15 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.
Collegium Pharmaceutical reported $780.57 million in revenue for fiscal year 2025, up 23.6% from $631.45 million in fiscal year 2024.
$719.15 million as of October 9, 2026.
Listed companies of a similar size in the same industry (opioid pain relief pharmaceuticals) include Ensysce Biosciences, Inc. (ENSC), Avenue Therapeutics, Inc. (ATXI), Trevena, Inc. (TRVN).